Literature DB >> 31982396

Expression assessment of a panel of long non-coding RNAs in gastric malignancy.

Farbod Esfandi1, Tayebeh Salehnezhad2, Mohammad Taheri3, Mandana Afsharpad4, Asghar Ashrafi Hafez5, Vahid Kholghi Oskooei1, Soudeh Ghafouri-Fard6.   

Abstract

BACKGROUND: Long non-coding RNAs (lncRNAs) have several important functions in the regulation of cell homeostasis and cell fate. Consequently, abnormal transcription of lncRNAs has been correlated with malignant transformation of cells. These human transcripts have been shown to participate in the progression of gastric cancer.
METHODS: In the current project, we evaluated expression of a panel of lncRNAs including HULC, MALAT1, FAS-AS1, GAS5, PVT1, OIP5-AS1 and THRIL in 30 gastric cancer tissues and paired adjacent non-cancerous tissues (ANCTs) using quantitative real-time PCR.
RESULTS: HULC, OIP5-AS1 and THRIL transcription quantities were significantly lower in gastric tumors compared to ANCTs (P values = .02, 0.02 and 0.007, respectively). Relative transcription quantities of HULC, MALAT1, OIP5-AS1, PVT1, FAS-AS1 and THRIL were associated with the site of the primary tumor (P values = .002, 0.003, 0.002, 0.002, 0.002, and 0.001, respectively). Moreover, relative expression levels of PVT1 were associated with history of smoking (P value = .04). Correlations were identified between transcript quantities of these lncRNAs in both tumor samples and ANCTs. Receiver operating characteristic curve assessment demonstrated that THRIL had the highest diagnostic power among the mentioned lncRNAs (area under curve (AUC) = 0.72, P value = .001). HULC and OIP5-AS1 ranked afterwards (AUC values of 0.69 and 0.68; P values = .005 and 0.007, respectively).
CONCLUSION: The current investigation underscores the dysregulation of these transcripts in gastric cancer specimens and suggests a number of these transcripts for further assessments of their suitability as cancer biomarkers.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FAS-AS1; GAS5; Gastric cancer; HULC; MALAT1; OIP5-AS1; PVT1; THRIL; lncRNA

Year:  2020        PMID: 31982396     DOI: 10.1016/j.yexmp.2020.104383

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

Review 1.  The role of lncRNA OIP5-AS1 in cancer development and progression.

Authors:  Cheng Zheng; Man Chu; Qiuli Chen; Cheng Chen; Zhi-Wei Wang; Xiao Chen
Journal:  Apoptosis       Date:  2022-03-22       Impact factor: 4.677

2.  LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer.

Authors:  Yi Cai; Yang Li; Bin Sun; Hugen Wang; Weiping Zhang; Yuanyuan Zhao; Haodong Zhao; Jianlin Zhang; Jianming Xu; Yalei Wang
Journal:  Cancer Manag Res       Date:  2020-09-16       Impact factor: 3.989

Review 3.  GAS5‑mediated regulation of cell signaling (Review).

Authors:  Yang Zhou; Binghai Chen
Journal:  Mol Med Rep       Date:  2020-08-19       Impact factor: 2.952

4.  Polygenic Risk Scores for Prediction of Gastric Cancer Based on Bioinformatics Screening and Validation of Functional lncRNA SNPs.

Authors:  Fujiao Duan; Chunhua Song; Peng Wang; Hua Ye; Liping Dai; Jianying Zhang; Kaijuan Wang
Journal:  Clin Transl Gastroenterol       Date:  2021-11-18       Impact factor: 4.488

5.  LncRNA THRIL is involved in the proliferation, migration, and invasion of rheumatoid fibroblast-like synoviocytes.

Authors:  Yaoyao Zou; Chuyu Shen; Ting Shen; Jingnan Wang; Xuepei Zhang; Qian Zhang; Runlu Sun; Lie Dai; Hanshi Xu
Journal:  Ann Transl Med       Date:  2021-09

6.  Aberrant Non-Coding RNA Expressed in Gastric Cancer and Its Diagnostic Value.

Authors:  Zhilong Yu; ZeYin Rong; Jinxin Sheng; Zai Luo; Jianming Zhang; Tengfei Li; Zhonglin Zhu; Zhongmao Fu; Zhengjun Qiu; Chen Huang
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.